Clinical Trial

Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque

Study acronym: Rosuzet-IVUS
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The aim of this prospective, open-label, randomized, single center study is to compare the effect of usual dose rosuvastatin plus ezetimibe and high-dose rosuvastatin on modifying atherosclerotic plaque.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2017-05-26; most recent amendment 2025-07-13.
Status change: Recruiting → Active, Not Recruiting 2025-07-13
Status change: Active, Not Recruiting → Recruiting 2025-05-14
Status change: Recruiting → Active, Not Recruiting 2024-04-19
Status change: Not Yet Recruiting → Recruiting 2017-10-10
Trial Details
NCT Number NCT03169985
Lead Sponsor Samsung Medical Center
Collaborators: Hanmi Pharmaceutical co., ltd.
Conditions Coronary Artery Disease
Enrollment 280 participants
Start Date 2017-07-12
Primary Completion 2027-01-28 (estimated)
Study Completion 2027-01-28 (estimated)
Updated on ClinicalTrials.gov 2025-07-16